Recent Advances in CAR-Based Solid Tumor Immunotherapy

Adoptive cell therapy using chimeric antigen receptor (CAR) technology is one of the most advanced engineering platforms for cancer immunotherapy. CAR-T cells have shown remarkable efficacy in the treatment of hematological malignancies. However, their limitations in solid tumors include an immunosu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Min Hwa, Oh, Eunha, Kim, Yunjeong, Nam, Dae-Hwan, Jeon, So Young, Yu, Jin Hyuk, Minn, Dohsik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297050/
https://www.ncbi.nlm.nih.gov/pubmed/37371075
http://dx.doi.org/10.3390/cells12121606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297050/
https://www.ncbi.nlm.nih.gov/pubmed/37371075
http://dx.doi.org/10.3390/cells12121606

Ejemplares similares